F-group (family)
2002.1.1.73 TGT
Ligands and drugs
836
Member domains
220
with ligand contacts (≤ 4 Å)
26.3% of members
216
with DrugDomain annotations
25.8% of members
175
with a DrugBank compound
20.9% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 2002.1.1.73 belongs to X-group 2002 TIM beta/alpha-barrel, which binds 8.7 ligand superclasses per 20 proteins, broader than 71% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03304 | PRF | 7-Deaza-7-Aminomethyl-Guanine | 9 |
| DB14732 | QEI | Queuine | 8 |
| DB04356 | 9DG | 9-Deazaguanine | 6 |
| DB02377 | GUN | Guanine | 5 |
| DB08267 | NE8 | 6-amino-4-(2-phenylethyl)-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one | 5 |
| DB03074 | PQ0 | 7-cyano-7-deazaguanine | 4 |
| DB07564 | CKR | 6-amino-2-[(2-morpholin-4-ylethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one | 4 |
| DB00142 | GLU | Glutamic acid | 3 |
| DB07704 | E89 | 6-AMINO-4-[2-(4-METHOXYPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE | 3 |
| DB08268 | NEZ | 6-AMINO-4-[2-(4-METHYLPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE | 3 |
| DB02441 | BDI | 2-Butyl-5,6-Dihydro-1h-Imidazo[4,5-D]Pyridazine-4,7-Dione | 2 |
| DB03505 | DQU | 2,6-diaminoquinazolin-4-ol | 2 |
| DB04543 | AIQ | 2,6-Diamino-8-(1h-Imidazol-2-Ylsulfanylmethyl)-3h-Quinazoline-4-One | 2 |
| DB00302 | AMH | Tranexamic acid | 1 |
| DB01825 | MAQ | 2-amino-8-methyl-4(1H)-quinazolinone | 1 |
| DB01833 | GGB | Canavanine | 1 |
| DB01875 | AZA | 8-azaxanthine | 1 |
| DB02041 | APZ | Isoluminol | 1 |
| DB02599 | APQ | 2,6-Diamino-8-Propylsulfanylmethyl-3h-Quinazoline-4-One | 1 |
| DB03780 | AQO | 2-Aminoquinazolin-4(3h)-One | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| ZNmetal | ZINC ION | 218 |
| CL | CHLORIDE ION | 35 |
| 9DG | 9-DEAZAGUANINE | 9 |
| PRF | 7-DEAZA-7-AMINOMETHYL-GUANINE | 9 |
| QEI | 2-amino-5-({[(1S,4S,5R)-4,5-dihydroxycyclopent-2-en-1-yl]amino}methyl)-3,7-dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-one | 8 |
| GUN | GUANINE | 5 |
| NE8 | 6-AMINO-4-(2-PHENYLETHYL)-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE | 5 |
| 726 | 6-azanyl-2-(methylamino)-4-[2-[(2~{R},3~{R},4~{S},5~{R},6~{S})-3,4,5,6-tetramethoxyoxan-2-yl]ethyl]-1,7-dihydroimidazo[4,5-g]quinazolin-8-one | 4 |
| 72C | 4-[2-[(3~{a}~{R},4~{R},6~{R},6~{a}~{R})-4-methoxy-2,2-dimethyl-3~{a},4,6,6~{a}-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]ethyl]-6-azanyl-2-(methylamino)-1,7-dihydroimidazo[4,5-g]quinazolin-8-one | 4 |
| BR | BROMIDE ION | 4 |
| CKR | 6-amino-2-[(2-morpholin-4-ylethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one | 4 |
| Kmetal | POTASSIUM ION | 4 |
| PQ0 | 2-AMINO-4-OXO-4,7-DIHYDRO-3H-PYRROLO[2,3-D]PYRIMIDINE-5-CARBONITRILE | 4 |
| 2WU | 6-amino-2-(methylamino)-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one | 3 |
| E89 | 6-AMINO-4-[2-(4-METHOXYPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE | 3 |
| ITE | 2-(methylamino)-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one | 3 |
| NEZ | 6-AMINO-4-[2-(4-METHYLPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE | 3 |
| OQN | 6-amino-2-(methylamino)-4-phenethyl-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one | 3 |
| TEW | 6-tungstotellurate(VI) | 3 |
| 0V3 | 6-amino-2-(methylamino)-4-[2-({[trans-4-(pyridin-3-ylethynyl)cyclohexyl]methyl}amino)ethyl]-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one | 2 |